Collaborators

 

The Computational Cardiovascular Science group works in close collaboration with clinical, experimental and industrial partners, and holds links with regulatory agencies such as the US FDA.

Hospitals (Cardiovascular Medicine)
John Radcliffe Hospital and Department of Cardiovascular Medicine, Oxford, UK Hugh Watkins, Barbara Casadei, Jurgen Schneider, Raj Kharbanda, Kim Rajappan, Erica Dall’Armellina, Rina Ariga
The Heart hospital, London, UK Peter Taggart, Ben Hanson, Pier Lambiase, Diogo Santos, Michele Orini.
Academia (Computational Methods)
Computer Science, Oxford University David Kay, The Chaste Team
Mathematical Institute, Oxford Unversity Helen Byrne, Heather Harrington
Bioingenieria Elettronica e Informatica University of Bologna, Italy Stefano Severi
Research Computing Centre, University of Queensland, Australia David Abramson
Dpto. de Ingeniería Electrónica y Comunicaciones, University of Zaragoza
Centro de Investigación Biomedica en Red, Spain		 Pablo Laguna, Esther Pueyo, Carlos Sanchez
Group of Bioelectronics (GBio-e), Universitat Politècnica de València Maria Guillen, Javier Saiz
INRIA, Bordeaux, France Nejib Zemzemi
The Fraunhofer-Chalmers Research Centre for Industrial Mathematics, FCC, Sweden Mikael Wallman
Faculty of engineering, The University of Auckland, New Zealand Nic Smith
School for Cardiovascular diseases CARIM, Maastricht, Netherlands John Walmsley
Barcelona Supercomputing Centre, Spain Mariano Vazquez
Department of Biomedical Engineering, National University of Singapore Alberto Corrías
Institute of Biosciences and Medical Technology, Tampere University of Technology, Finland Jari Hyttinen, Michelangelo Paci
Academia (Experimental Physiology and Pharmacology)
Department of Physiology, Anatomy and Genetics, University of Oxford, UK Gil Bub, Rebecca Burton, David Paterson
Department of Chemistry, University College London, UK Peter Coveney
Department of Pharmacology and Pharmacotherapy, Szeged University, Hungary Istvan Laczko, Andras Varro, Laszlo Virag
National Lung & Heart Institute, Imperial College London, UK Peter Kohl
Department Biomedical Engineering, Washington University in St Louis, USA Igor Efimov
Insigneo Institute for in silico Medicine Richard Clayton
Institute of Pharmacology and Toxicology, Dresden University, Germany Ursula Ravens, Eric Wettwer
Department of physiology & biophysics , Dalhousie University, Halifax, Canada T. Alexander Quinn
Department of Biotechnology and Bioscience, University of Milano-Bicocca. Antonio Zaza
Department Cardiac Electrophysiology, Queen Mary University, London, UK Andrew Tinker
Instituto de Investigación Sanitaria Greforio Marañón. Madrid Andreu M. Climent, Alejandro Liberos
Industry
Amgen Inc., USA
Anabios Corporation
AstraZeneca, UK
Clyde Biosciences
IBM, Melbourne and IBM, USA
Johnson & Johnson (Janssen Pharmaceutical), Belgium
Merck MSD, USA
Notocord
Novartis
Oxford Consulting Computing, UK
QT Informatics
UCB Pharma S.A.
Government
Food and Drug Administration, USA